Motivational Enhancement System for Adherence
Public ClinicalTrials.gov record NCT01009749. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a two-phase study, consisting of the following plan: Phase I - This is a pre-test of the feasibility and acceptability of the beta version of a computer-delivered intervention, Motivational Enhancement System for Adherence (MESA), as well as the control intervention Motivational Enhancement System for Health (MESH) at three selected AMTUs. Following analysis of the responses in Phase I and further modification of the intervention, Phase II will be initiated. Phase II - This is a pilot, randomized, controlled trial (RCT) testing a two-session computer-delivered intervention, MESA, designed to increase motivation for adherence to Highly Active Antiretroviral Therapy (HAART) among youth newly recommended to begin medications, as well as an attention control, MESH, matched for dose and delivery format. Phase II is open to all 15 AMTUs.
Study identification
- NCT ID
- NCT01009749
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 76 participants
Conditions and interventions
Conditions
Interventions
- Motivational Enhancement System for Adherence (MESA) Behavioral
- Motivational Enhancement System for Health (MESH) Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 16 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2009
- Primary completion
- Apr 30, 2011
- Completion
- Apr 30, 2011
- Last update posted
- Jul 31, 2017
2009 – 2011
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hopsital of Los Angeles | Los Angeles | California | 90027 | — |
| Univ of Califormia at San Francisco | San Francisco | California | 94143 | — |
| Children's Hosp Natinal Med Center | Washington D.C. | District of Columbia | 20010 | — |
| Children's Diagnostic and Treatment Center | Fort Lauderdale | Florida | 33316 | — |
| University of Miami-Jackson Memorial Medical Center | Miami | Florida | 33101 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Stoger Hospital of Cook County | Chicago | Illinois | 60612 | — |
| Tulane Medical Center | New Orleans | Louisiana | 70112 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Mount Sinai Medical Center | New York | New York | 10128 | — |
| Children's Hospital at Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Children's Hopsital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| St. Jude Childrens Research Hospital | Memphis | Tennessee | 38105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01009749, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01009749 live on ClinicalTrials.gov.